Sophion Bioscience - Pioneering Ion Channels

Pioneering
ion channels

Sophion

[From Sophia + Ion: Greek σοφία, “wisdom” the ability to think and act using knowledge, experience, understanding and insight, the capacity of judging rightly]

 

Sophion was founded almost twenty years ago by a group of passionate electrophysiologists, all having the shared purpose of making patch clamping objective and independent of user skills to provide faster, more accurate and objective patch clamping results. “To take the voodoo out of patch clamping”. Over the past twenty years, we have developed from a startup into a global organization, but the passion and drive to provide high-performance patch clamp solutions persists.

 

With our complete technical, biological and application support we help our partners to achieve their targets, and through continued development of our QPatch and Qube platforms, we ensure that we offer uncompromised data quality in a user-friendly environment from assay setup to data analysis.

QPatch II

Improving the benchmark for cardiac safety

Qube 384

High throughput ion channel screening made easy

Disease areas

Pain

Ion channels are involved in both initiating and transmitting pain

Cardiovascular

Ion channels are key in drug safety studies and important target for many heart diseases

CNS

Evidence suggest that ion channels play a key role in psychiatric diseases

Cancer

Ion channels play an emerging role as potential drugable targets for cancer treatments

Other

Read more about other disease areas driven by ion channel malfunction